Skip to main content

Advertisement

Table 1 Investigated concentration thresholds

From: Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants

Investigated concentrations Rivaroxaban (ng/mL) Apixaban (ng/mL) Dabigatran (ng/mL)
DOAC concentrations proposed as safe for surgery [1012] 30 NA 30, 48, 50
DOAC concentrations that may permit thrombolysis with rtPA [14] 100 10 50
  1. DOAC direct oral anticoagulants, NA not available, rtPA recombinant tissue plasminogen activator